Desmopressin is used for the treatment of neurogenic diabetes mellitus, primary nocturnal enuresis (with normal urine concentration), transient hyperuria with trauma or surgery in the pituitary region, von Willebrand disease type I, mild hemophilia type A and thrombocytopenia.
Clinical use of desmopressin in pregnant women has shown that the drug has no adverse effects on the fetus. Controlled studies on humans have not been performed. Given that animal studies are not always predictive of the drug's effect on humans. This medicine should be used during pregnancy only if there is a definite need. Desmopressin after taking 10 micrograms intranasally, like many drugs, is excreted in breast milk in a very small amount. Therefore, caution should be taken when using it in lactating women.
Dosage of nasal desmopressin in adults:
For the treatment of central insipid diabetes, take 10 to 40 micrograms (1 to 4 puffs) in one day or in two or three divided doses.
Dosage of nasal desmopressin in children:
- For the treatment of central diabetes mellitus in children up to 3 months. No doses have been suggested yet.
- For children aged 3 months to 12 years. 5 to 30 micrograms are given daily in single doses or in two divided doses. Since the nasal spray does not provide less than 0 to 1 micrograms, the Rhinal Tube Delivery system should be used in patients who require doses of less than 10 micrograms.
Dosage of nasal desmopressin in the elderly:
In the elderly, treatment with this drug should be started with caution and in small doses.